Streetbeat News

Products Services

GOOGL

Google (NASDAQ:GOOGL) has filed a lawsuit against two Chinese nationals for creating fake cryptocurrency investment apps on the Google Play store, defrauding over 100,000 users globally. The lawsuit seeks damages over $75,000 and aims to set a precedent to deter future scams. Google's actions highlight the ongoing battle against online financial scams, especially in the cryptocurrency space.

Portfolio Pulse from Murtuza Merchant

April 05, 2024 | 2:21 pm

NVDA

TSLA

Tesla Inc.'s CEO Elon Musk disagrees with Nvidia Corp.'s CEO Jensen Huang on the ease of creating neural networks. Musk responded to Huang's claim that anyone could use Nvidia's AI chips for this purpose, stating it's 'insanely hard'. This comes as Tesla has invested in Nvidia's GPUs for its self-driving technology. Huang remains optimistic about Nvidia's AI capabilities and its software segment's revenue, despite Musk's skepticism.

Portfolio Pulse from Rounak Jain

April 05, 2024 | 2:20 pm

AZN

AstraZeneca Plc (NASDAQ:AZN) announced promising results from the ADRIATIC Phase 3 trial of Imfinzi, either alone or with Imjudo, in treating small cell lung cancer (LS-SCLC) post-chemoradiotherapy. The trial, involving 730 patients, showed significant improvements in overall and progression-free survival compared to placebo. Imfinzi's safety profile remained consistent, with no new safety concerns. The study's second arm, evaluating Imjudo's addition, continues to its next analysis phase. Imfinzi is already approved in multiple regions for different stages of lung cancer.

Portfolio Pulse from Vandana Singh

April 05, 2024 | 2:19 pm

IYG

MA

V

XLF

Mastercard Inc (NYSE:MA) announced new partnerships with brands like Alo Moves, Booking.com, and Lyft to enhance credit card rewards, coinciding with an upcoming fee hike. The partnerships aim to provide value in health & wellness, travel, and lifestyle sectors, reflecting consumer demand for rewards. Mastercard's research shows 87% of American consumers value credit card rewards highly. The company also plans to increase its 'assessment' fee from 0.13% to 0.14%, which is expected to generate an additional $259.1 million in fees. Mastercard's stock has risen 30% over the last 12 months, and it can be accessed through ETFs like IShares U.S. Financial Services ETF (NYSE:IYG) and SPDR Select Sector Fund – Financial (NYSE:XLF).

Portfolio Pulse from Anusuya Lahiri

April 05, 2024 | 2:04 pm

META

Meta plans to expand its labeling of AI-generated content to include a broader range of video, audio, and image content starting in May. This decision comes as a response to feedback indicating that the current labeling policies are too narrow. The new labels aim to address the increasing variety of AI-generated and manipulated content. Meta's approach includes labeling content as 'Made with AI' through self-disclosure, advice from fact-checkers, or detection of AI markers. This policy update follows recommendations from Meta's independent Oversight Board and extends beyond the existing 'manipulated media' rules.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 2:01 pm

NTRA

Natera's stock price increased following the announcement of positive analysis results from the IMvigor011 study in muscle-invasive bladder cancer. Additionally, Bernstein upgraded Natera's stock from Market Perform to Outperform with a $120 price target.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 1:59 pm

BA

NVDA

SBUX

Barbara Doran of BD8 Capital Partners has revealed her top stock picks, showing a bullish stance on Boeing (BA), Nvidia (NVDA), and Starbucks (SBUX). Despite Boeing's recent challenges, Doran is optimistic due to upcoming leadership changes. Nvidia's stock has surged 240% in 2023, and despite being considered overvalued by some, Doran sees further potential. Starbucks, despite a 14% drop in shares over the past year, is viewed positively by Doran for its expansion plans and recent leadership restructuring.

Portfolio Pulse from Benzinga Neuro

April 05, 2024 | 1:50 pm

RDY

Dr. Reddy's Laboratories Ltd. (RDY) and Bayer have formed a partnership to market and distribute a second brand of Vericiguat, named Gantra, in India. This agreement grants Dr. Reddy's non-exclusive rights to sell Gantra, aimed at treating adults with symptomatic chronic heart failure. Vericiguat represents a novel approach in heart failure treatment, potentially reducing cardiovascular death and hospitalization risks. India, with 8-10 million heart failure patients, represents a significant market for this treatment.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 1:46 pm

XXII

22nd Century Group, Inc. (NASDAQ:XXII), a tobacco products company, announced a new contract manufacturing agreement expected to increase its carton production volumes by over 20%. The contract starts in Q2 2024, aligning with the company's goals to grow its contract manufacturing business and its VLN® franchise focused on tobacco harm reduction. This move is anticipated to scale revenue, improve gross margin, and achieve breakeven operations by Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 1:43 pm

SSNLF

Samsung Electronics Co (OTC:SSNLF) is expected to see a significant rise in its first-quarter operating profit, reaching 6.6 trillion won ($4.9 billion), a tenfold increase from the previous year. This growth is attributed to a recovery in the memory semiconductor market. Despite this, Samsung's stock has underperformed due to issues with High Bandwidth Memory (HBM). Analysts predict that AI demand, particularly from companies like Nvidia, will drive the need for specialized storage chips, potentially stabilizing the market and boosting Samsung's semiconductor sales.

Portfolio Pulse from Benzinga Neuro

April 05, 2024 | 1:32 pm